Frontlight ResearchEarly access
Asthma trials in Hong Kong
1 of 7 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Active, not recruitingA Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in Symptomatic Chinese Adults With Asthma
- Where
- Hong Kong
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06471257